Escaping from rejection

Transplantation

Volumn 88, Issue 11, 2009, Pages 1233-1236

  Lynch, Raymond J ^a   Platt, Jeffrey L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Accommodation; Allograft Rejection; Host defense.; T cell; Tolerance

Indexed keywords

HAPTEN;

ALLOTRANSPLANTATION; B LYMPHOCYTE; BLOOD GROUP ABO INCOMPATIBILITY; GRAFT REJECTION; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; IMMUNOCYTOTOXICITY; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; XENOTRANSPLANTATION; ADAPTIVE IMMUNITY; ANIMAL; BIOLOGICAL MODEL; GRAFT SURVIVAL; IMMUNOLOGY; INNATE IMMUNITY; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; XENOGRAFT;

ADAPTIVE IMMUNITY; ANIMALS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; TRANSPLANTATION; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 73349110427     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bcc93a     Document Type: Review

References (52)

1. Ehrlich P, Morgenroth J. Studies on haemolysins. In: Ehrlich P, ed. Studies in immunity. New York, Wiley 1910, p 82.
2. Sponaas AM, Tomlinson PD, Schulz R, et al. Tolerance induction by eliminationof subsetsof self-reactive thymocytes. Int Immunol 1994; 6: 1593.
3. McHeyzer-Williams MG, Nossal GJ. Clonal analysis of autoantibody- producing cell precursors in the preimmune B cell repertoire. J Immunol 1988; 141: 4118.
4. Ehrlich P. On immunity with special reference to cell life. Proc R Soc London 1900; 66: 424.
5. Robinson JH, Owen JJ. Transplantation tolerance induced in foetal mouse thymus in vitro. Nature 1978; 271: 758.
6. Burnet FM, Fenner F. The production of antibodies [ed. 2]. Melbourne, Macmillan 1949.
7. Silverstein AM, Rose NR. On the mystique of the immunological self. Immunol Rev 1997; 159: 197.
8. Fan X, Tyerman K, Ang A, et al. A novel tool for B-cell tolerance research: Characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique. Transplant Proc 2005; 37: 29.
9. Fan X, Ang A, Pollock-BarZiv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10: 1227.
10. Ogle BM, Cascalho M, Joao CM, et al. Direct measurement of lymphocyte receptor diversity. Nucleic Acids Res 2003; 31: e139.
11. Cervera R. The epidemiology and significance of autoimmune diseases in health care. Scand J Clin Lab Invest Suppl 2001; 235: 27.
12. Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol2000; 53: 424.
13. Sinclair D. Analytical aspects of thyroid antibodies estimation. Autoimmunity 2008; 41: 46.
14. Zozaya J. Combination of bacterial polysaccharides and collodion particles as antigens. Science 1931; 74: 270.
15. Freund J. A method of immunization with carbohydrate haptens adsorbed on collodion particles. Science 1932; 75: 418.
16. Chen TC, Cobbold SP, Fairchild PJ, et al. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J Immunol 2004; 172: 5900.
17. Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042.
18. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12: 991.
19. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homo-logue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394.
20. Johnson GB, Brunn GJ, Tang AH, et al. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003; 24: 19.
21. Ichikawa HT, Williams LP, Segal BM. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol 2002; 169: 2781.
22. Goswami R, Kochupillai N, Crock PA, et al. Pituitary autoimmunity in patients with Sheehan's syndrome. J Clin Endocrinol Metab 2002; 87:4137.
23. Whitby EH, Sparshott SM, Bell EB. Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities. Immunology 1990; 69: 78.
24. Gracie JA, Sarawar SR, Bolton EM, et al. Renal allograft rejection in CD4+ T cell-reconstituted athymic nude rats. The origin of CD4+ and CD8+ graft-infiltrating cells. Transplantation 1990; 50: 996.
25. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat 1943;77: 299.
26. Zinkernagel RM, Doherty PC. Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis. J Exp Med 1973; 138: 1266.
27. Titus RG, Milon G, Marchal G, et al. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol 1987; 17: 1429.
28. Wong P, Pamer EG. CD8 T cell responses to infectious pathogens. Annu Rev Immunol 2003; 21: 29.
29. Tang AH, Platt JL. Accommodation of grafts: Implications for health and disease. Hum Immunol 2007; 68: 645.
30. Platt JL, Vercellotti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: A review of progress. Immunol Today 1990; 11: 450.
31. Chopek MW, Simmons RL, Platt JL. ABO-incompatible renal transplantation: Initial immunopathologic evaluation. Transplant Proc 1987; 19: 4553.
32. Bannett AD, McAlack RF, Morris M, et al. ABO incompatible renal transplantation: A qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 1989; 21: 783.
33. Jeannet M, Benzonana G, Arni I. Donor-specific B and T lymphocyte antibodies and kidney graft survival. Transplantation 1981; 31: 160.
34. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implicationsofdevelopmentof donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16: 2804.
35. Piazza A, Poggi E, Ozzella G, et al. Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: Results of sixteen-year monitoring by flow cytometry. Clin Transpl 2006: 323.
36. Vaile JH, Dyke L, Kherani R, et al. Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 2000; 18: 433.
37. Andrejevic S, Bonaci-Nikolic B, Sefik-Bukilica M, et al. Clinical and serological follow-up of 71 patients with anti-mitochondrial type 5 antibodies. Lupus 2007; 16: 788.
38. Lynch RJ, Platt JL. Accommodation in organ transplantation. Curr Opin Organ Transplant 2008; 13: 165.
39. Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-upofHLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005; 5: 2265.
40. Bonifaz V, Shan Y, Lambrecht RW, et al. Effects of silymarin on hepatitis C virus and haem oxygenase-1 gene expression in human hepa-toma cells. Liver Int 2009; 29: 366.
41. Platt JL, Nath KA. Heme oxygenase: Protective gene or Trojan horse. Nat Med 1998; 4: 1364.
42. Polack FM. Inhibition of immune corneal graft. Rejection by azathio-prine (Imuran). Arch Ophthalmol 1965; 74: 683.
43. Yu PB, Holzknecht ZE, Bruno D, et al. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 1996; 157: 5163.
44. Mohiuddin MM, Ogawa H, Yin DP, et al. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation 2003; 75: 258.
45. Bustos M, Coffman TM, Saadi S, et al. Modulation of eicosanoid metabolism in endothelial cells in a xenograft model: Role of cyclooxygenase-2. J Clin Invest 1997; 100: 1150.
46. Reiter Y, Ciobotariu A, Fishelson Z. Sublytic complement attack protects tumor cells from lytic doses of antibody and complement. Eur J Immunol 1992; 22: 1207.
47. Reiter Y, Ciobotariu A, Jones J, et al. Complement membrane attack complex, perforin, and bacterial exotoxins induce in K562 cells calcium-dependent cross-protection from lysis. J Immunol 1995; 155: 2203.
48. Fan H, Cook JA. Molecular mechanisms of endotoxin tolerance. J En-dotoxin Res 2004; 10: 71.
49. Zhong B, Ma HY, Yang Q, et al. Decrease in toll-like receptors 2 and 4 in the spleen of mouse with endotoxic tolerance. Inflamm Res 2008; 57: 252.
50. Suciu-Foca N, Manavalan JS, Scotto L, et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: Review. Int Immunopharmacol 2005; 5: 7.
51. Kabalak G, Koch S, Dobberstein B, et al. Immunoglobulin-like tran-scriptsasrisk genes for autoimmunity. Ann NY Acad Sci2007; 1110: 10.
52. Suciu-Foca N, Feirt N, Zhang QY, et al. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J Immunol 2007; 178: 7432.